Weekly News Recap #Phispers
FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca’s new treatment for hypertension
In Phispers this week, the US Food and Drug Administration (FDA) approved AstraZeneca’s first-in-class treatment for hype...
Impressions : 2229
Merck buys Terns Pharma for US$ 6.7 bn to boost cancer portfolio; Novartis acquires Synnovation unit for up to US$ 3bn
This week’s Phispers is packed with news of drug approvals and M&As. Merck is preparing for its future post-Keytruda pate...
Impressions : 1005
Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines
The New Year began with two mid-size deals centered around the use
of artificial intelligence (AI) in drug development. Sanofi...
Impressions : 1503
EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3983
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.